Faculty Position

St. Jude Children's Research Hospital•Memphis, TN

2d•Onsite

About The Position

The Comprehensive Cancer Center at St. Jude Children’s Research Hospital is launching a major recruiting effort for multiple laboratory-based faculty at the FULL, ASSOCIATE and ASSISTANT levels as we undergo a significant expansion of our basic and translational research programs. We are seeking creative and collaborative scientists with vibrant research programs focused on 1) diverse areas of basic science with relevance for cancer; 2) translational, laboratory-based investigation related to pediatric brain tumors and solid tumors; and 3) translational, laboratory-based investigation related to hematological malignancies as part of a newly formed Center for Excellence in Leukemia Studies. St. Jude Children’s Research Hospital is a world-class research institution dedicated to pediatric cancer and other catastrophic diseases of childhood. We are the first and only National Cancer Institute (NCI)-designated Comprehensive Cancer Center devoted solely to children and have been recognized with the highest possible ranking of “exceptional” in our two most recent five-year reviews by the NCI. Our mission is to advance research and cures for pediatric cancer, the number one cause of death by disease for U.S. children past infancy. St. Jude is a highly interactive environment offering its faculty a remarkable opportunity to perform cutting-edge independent and collaborative research while receiving long-term institutional support past start-up to facilitate innovation and discovery. As a member of the Cancer Center, you will also have access to extensive, state-of-the-art shared resources staffed by PhD-level scientists and will join a collaborative network of basic, translational, and clinical investigators conducting high-impact, interdisciplinary research. Investigators have access to resources developed at St. Jude relevant to pediatric cancer, including genomic data in St. Jude Cloud and extensive repositories of patient-derived xenografts matched to primary patient samples and data.